These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37325244)

  • 41. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.
    Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaginal multipurpose prevention technologies: promising approaches for enhancing women's sexual and reproductive health.
    Fernandes T; Baxi K; Sawarkar S; Sarmento B; das Neves J
    Expert Opin Drug Deliv; 2020 Mar; 17(3):379-393. PubMed ID: 32036727
    [No Abstract]   [Full Text] [Related]  

  • 43. Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.
    Thurman AR; Clark MR; Hurlburt JA; Doncel GF
    Int J Womens Health; 2013 Oct; 5():695-708. PubMed ID: 24174884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "I felt like a TRIO champion": end-user perspectives on their role as co-designers of multi-purpose technologies.
    Agot K; Lutnick A; Shapley-Quinn MK; Ahmed K; Okello T; van der Straten A;
    Gates Open Res; 2020; 4():163. PubMed ID: 33870103
    [No Abstract]   [Full Text] [Related]  

  • 45. Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy.
    Young IC; Benhabbour SR
    Polymers (Basel); 2021 Jul; 13(15):. PubMed ID: 34372059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study.
    van der Straten A; Ryan JH; Reddy K; Etima J; Taulo F; Mutero P; Taylor J; Piper J; Musara P;
    J Int AIDS Soc; 2020 Jun; 23(6):e25536. PubMed ID: 32524700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Designing a multipurpose technology for acceptability and adherence.
    Tolley EE; Morrow KM; Owen DH
    Antiviral Res; 2013 Dec; 100 Suppl(0):S54-9. PubMed ID: 24188706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Program impact and potential pitfalls of multi-purpose technologies (MPTs) for HIV prevention and contraception.
    Latka MH; Vahle K; Li K; Gomes M; Dam A
    Front Reprod Health; 2023; 5():1249979. PubMed ID: 37727532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.
    Smith JM; Moss JA; Srinivasan P; Butkyavichene I; Gunawardana M; Fanter R; Miller CS; Sanchez D; Yang F; Ellis S; Zhang J; Marzinke MA; Hendrix CW; Kapoor A; Baum MM
    PLoS One; 2017; 12(10):e0185946. PubMed ID: 28982161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomedical, socio-behavioral, and implementation science gaps in multipurpose prevention technology research.
    Cummins JE; Allen CL; Lee S; Senn TE
    Front Reprod Health; 2023; 5():1244659. PubMed ID: 37744288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa.
    Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Kilbourne-Brook M; Mvundura M; Delany-Moretlwe S; Terris-Prestholt F
    Med Decis Making; 2018 Jan; 38(1):120-133. PubMed ID: 28863752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rational Design of a Multipurpose Bioadhesive Vaginal Film for Co-Delivery of Dapivirine and Levonorgestrel.
    Li J; Regev G; Patel SK; Patton D; Sweeney Y; Graebing P; Grab S; Wang L; Sant V; Rohan LC
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31861267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preferences for Multipurpose Technology and Non-oral Methods of Antiretroviral Therapy Among Women Living With HIV in Western Kenya: A Survey Study.
    Bernard C; Jakait B; Fadel WF; Mocello AR; Onono MA; Bukusi EA; Wools-Kaloustian KK; Cohen CR; Patel RC
    Front Glob Womens Health; 2022; 3():869623. PubMed ID: 35663925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward.
    Torres-Rueda S; Terris-Prestholt F; Gafos M; Indravudh PP; Giddings R; Bozzani F; Quaife M; Ghazaryan L; Mann C; Osborne C; Kavanagh M; Godfrey-Faussett P; Medley G; Malhotra S
    Pharmacoeconomics; 2023 Jul; 41(7):787-802. PubMed ID: 36905570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
    Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
    [No Abstract]   [Full Text] [Related]  

  • 56. Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic.
    Tolley EE; Zissette S; Taylor J; Hanif H; Ju S; Schwarz J; Thurman A; Tyner D; Brache V; Doncel GF
    J Womens Health (Larchmt); 2022 Sep; 31(9):1343-1352. PubMed ID: 35363574
    [No Abstract]   [Full Text] [Related]  

  • 57. Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019.
    McLellan-Lemal E; Deaton SR; Betts JE; Ondenge K; Mudhune V; O'Connor SM; Nyagol B; Thurman AR; Doncel GF; Allen SA; Heffron R; Mugo NR;
    Contemp Clin Trials; 2022 Nov; 122():106935. PubMed ID: 36162740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence and gap map report: Social and Behavior Change Communication (SBCC) interventions for strengthening HIV prevention and research among adolescent girls and young women (AGYW) in low- and middle-income countries (LMICs).
    Bose DL; Hundal A; Singh S; Singh S; Seth K; Hadi SU; Saran A; Joseph J; Goyal K; Salve S
    Campbell Syst Rev; 2023 Mar; 19(1):e1297. PubMed ID: 36911864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards a roadmap to advance non-hormonal contraceptive multipurpose prevention technologies: strategic insights from key stakeholders†.
    Hemmerling A; Christopher E; Young Holt B
    Biol Reprod; 2020 Aug; 103(2):289-298. PubMed ID: 32639007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Developing multipurpose reproductive health technologies: an integrated strategy.
    Harrison PF; Hemmerling A; Romano J; Whaley KJ; Young Holt B
    AIDS Res Treat; 2013; 2013():790154. PubMed ID: 23533733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.